Rocket Doctor AI

Rocket Doctor AI ROE

Delisted

The Return on Equity (ROE) of Rocket Doctor AI (TRUE.CN) as of Nov 16, 2026 is -952.77 %. In the previous year, Return on Equity (ROE) was 504.32 % — a change of -288.92% (lower).

ROE

-952.77 %

YoY

-288.92%

Last updated:

In 2024, Rocket Doctor AI's return on equity (ROE) was -952.77 %, a -288.92% increase from the 504.32 % ROE in the previous year.

The Rocket Doctor AI ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2017
262.23 CAD
Jan 1, 2018
-701.00 CAD
Jan 1, 2019
-858.04 CAD
Jan 1, 2020
1,104.56 CAD
Jan 1, 2021
-12,615.29 CAD
Jan 1, 2022
173.48 CAD
Jan 1, 2023
504.32 CAD
Jan 1, 2024
-952.77 CAD
The Rocket Doctor AI ROE history
YEARROEYoY
-952.77 %-288.92%
504.32 %+190.71%
173.48 %-101.38%
-12,615.29 %-1,242.11%
1,104.56 %-228.73%
-858.04 %+22.40%
-701.00 %-367.32%
262.23 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rocket Doctor AI Stock analysis

What does Rocket Doctor AI do? Treatment.com AI Inc generates revenue through its Treatment Digital Health App, a symptom assessment tool developed by a global team of doctors and engineers. The app provides predictive health insights using disease rate estimates, geographic variation data, and medical research, targeting patients and caregivers seeking informed health decisions. The company also offers medical education solutions and clinical advisor services, serving healthcare professionals and institutions globally. Revenue streams include subscriptions for app access and tailored medical education programs. The Treatment Digital Health App is designed for widespread use, offering advanced medical knowledge access to users worldwide. Medical clinic solutions are integrated into the platform, supporting healthcare providers in decision-making. Clinical advisor services leverage the AI platform to assist clinics and institutions with specialized medical guidance. These offerings are marketed to healthcare consumers, clinics, and educational institutions as part of the company's global healthcare technology strategy. Treatment.com AI Inc's business model focuses on AI-driven health solutions, with the Treatment Digital Health App as its primary product. The app's predictive health assessments are updated regularly by medical professionals, ensuring relevance and accuracy. The company monetizes through direct consumer subscriptions and B2B partnerships with medical clinics and educational providers, emphasizing global accessibility and evidence-based medical insights. Rocket Doctor AI is one of the most popular companies on Eulerpool.

ROE Details

Decoding Rocket Doctor AI's Return on Equity (ROE)

Rocket Doctor AI's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Rocket Doctor AI's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Rocket Doctor AI's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Rocket Doctor AI’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Rocket Doctor AI stock

Return on Equity (ROE) of Rocket Doctor AI is -952.77 % in 2024.

Return on Equity (ROE) of Rocket Doctor AI changed from 504.32 % to -952.77 %, representing a -288.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Rocket Doctor AI since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Rocket Doctor AI with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Rocket Doctor AI

All Key Metrics — Rocket Doctor AI